Abstract
Introduction

Alzheimer's disease (AD) is characterized by the extracellular deposition of amyloid ␤ protein (A␤) aggregates in the brain
. Although high-molecular weight A␤ (hiMWA␤) oligomers, A␤ protofibrils and fibrils, low-molecular weight A␤ (loMWA␤) oligomers, such as dimers, trimers or A␤*56, have been observed in human AD brain tissue or in mouse models of AD [1] [2] [3] [4] [5] [6] [7] [8] [9] , it is not entirely clear which A␤ species are the most relevant ones for the development of AD and how these A␤ forms are related to one another in vivo. Some studies have used SDS-PAGE for protein analysis [3] [4] [5] 9] , which denatures and dissociates proteins into individual polypeptides before determining its molecular weight. By contrast, others have performed only dot blot analysis [6] . Currently, only size exclusion chromatography has been used to study oligomers in non-SDS-treated conditions [3, 9] 
. However, it is unclear whether interactions with the stationary phase may impact the aggregation state of hiMWA␤ species. A detailed analysis of the native A␤ aggregates in the AD brain using blue native-PAGE (BN-PAGE) in comparison with SDS-PAGE analysis that focuses on the identification of the above-mentioned forms of A␤ aggregates is still unavailable.
Antibodies and antibody fragments have been developed to detect specific hiMWA␤ oligomers (A11) and protofibrillar/fibrillar conformations (B10AP) [2, 6] . These 
Materials and methods
Neuropathology and human sample characterization
A sample including six AD and four control cases was studied (Table 1). All autopsy brains were collected from individuals who died in the University Hospitals of Bonn or Ulm (Germany). All human tissue was obtained and processed in compliance with German federal laws and with university ethics committee approval.
Demented as well as non-demented patients were examined 1-4 weeks prior to death using standardized protocols for routine clinical examination, including neurological status, upon admission to hospital. These data were used to determine whether individuals clinically fulfilled the DSM-IV criteria for dementia [11] . AD was diagnosed when dementia was observed and when the degree of AD-related neuropathology indicated at least a moderate likelihood for AD according to internationally acknowledged criteria [12] .
After assessment of unfixed tissue from one hemisphere for biochemical studies, the brains were fixed in a 4% aqueous formaldehyde solution for at least 3 weeks before undergoing neuropathological screening. Presence or absence of gross infarction, haemorrhage, tumour and other findings were recorded. Tissue blocks from the medial temporal lobe (MTL) were excised at the levels of the (i) anterior limit of the dentate gyrus and (ii) lateral geniculate body [13] . These blocks together with tissue blocks from the occipital cortex (Brodmann areas [17] [18] [19] [12, 14, 16, 17] . For staging of A␤ pathology, we used a previously published protocol for four phases of ␤-amyloidosis in the MTL [18] . This hierarchically based procedure facilitates study of the topographic distribution pattern of A␤ deposition in additional brain regions [18, 19] (Fig. 1A) Figure 3C. (Fig. 1A) . The high-molecular weight smear was also seen with anti-A␤1-17 at the level of stacking gel in AD cases (Fig. 1C) but not with anti-A␤40 (Fig. 1B) . However, the detection of synthetic A␤40 but not A␤42 indicated specific antibody function (Fig. 1B) . Anti-A␤1-17 stained an additional 150-250 kD band (Fig. 1C) that was also observable with anti-APP antibodies, thereby indicating that this band represents APP-containing material (Fig. 1D) . The APP-related band was also present in control cases, whereas the high-molecular weight anti-A␤1-17 smear was not seen (Fig. 1C) . [6] . (Fig. 3A, B) . (Fig. 1H ).
Fig. 1 Western blot analysis of sucrose soluble proteins from AD and control brains after BN-PAGE (A-D) and after SDS-PAGE (E-H
-10). (E)-(G) SDS-PAGE analysis of AD brain protein lysates from cases no. 5-10 exhibited A␤ monomer and dimer bands with MBC-42 (E), MBC-40 (F) and anti-A␤1-17 (G) that were not detected in control brains (cases no. 1-4). The MBC-42-dimer (E) and 6E10-dimer bands (G) were not seen in all AD cases, whereas anti-A␤40 consistently detected dimer bands (F). A high-molecular smear was found in most AD cases with all three antibodies directed against A␤. Interestingly, cases 6 and 10 exhibited nearly no SDS-stable hiMWA␤42 aggregates (E), whereas both cases showed high-molecular anti-A␤42-positive material in the BN-PAGE (A). (H) With the help of anti-A␤1-17 (6E10)-immunoprecipitation, monomer and dimer bands as well as loMWA␤ (4-20 kD) smears and hiMWA␤ (Ͼ160 kD) smears were visible in SDS-PAGE of AD brain lysates (cases no. 5-10) but not in those of controls (cases no. 1-4). The detection of the loMWA␤ oligomers required chemiluminescence exposure for 3 hrs (i.e. long exposure times). that was not found in controls. A␤ monomers, dimers, or other loMWA␤ species were not observed in AD cases or in controls
The BN-PAGE blots from brain samples were developed with a chemiluminescence exposure time of 2-3 hrs to detect even very minimal amounts of proteins. SDS-PAGE with subsequent anti-A␤42, anti-A␤40 and anti-A␤1-17 Western blot analysis showed A␤ monomers and dimers in AD cases (Fig. 1E-G). A␤ aggregates with a molecular weight of Ͼ160 kD were observed in four of six cases with anti-A␤42 and a smear Ͼ260 kD was observed in all cases with anti-A␤1-17 (6E10) (Fig. 1E-G). After immunoprecipitation with anti-A␤1-17, a smear of hiMWA␤-(Ͼ160 kD) and loMWA␤ aggregates (8-20 kD) as well as dimer bands at ~10 kD were consistently seen in AD
Fig. 2 Electron microscopic analysis of immunoprecipitated protein aggregates from AD and control brain as precipitated with B10AP-antibody fragments (B10AP-IP) and A11 antibodies (A11-IP). (A), (B) In
(E), (F) B10AP-IP from AD brain lysate of case no. 7 showed protein aggregates of protofibril-like morphology. Immunogold labelling indicated A␤1-17-positive proteins. The frame in E indicates the areas enlarged in (F). At higher magnification, A␤1-17-positive material following B10AP-IP exhibited protofibril-like morphology (arrows in F) and less frequently amorphous structures (arrowheads in F). These types of A␤ aggregates prevailed in B10AP precipitates. (G) Only a few precipitated A␤-positive protein aggregates exhibited fibrillar architecture (case no. 10) resembling synthetic A␤ fibrils
(H) A11-precipitated protein aggregates from AD case no. 7 exhibited spherical to amorphous morphology. Immunogold particles indicate the presence of A␤1-17-positive aggregates. (I)-(J) Similarly, A11-IP extracted mainly spherical and amorphous protein aggregates from AD case no. 10 shown here at higher magnification. Immunogold labelling indicated A␤1-17-positive proteins. The frame indicates the area enlarged in (J). The A␤1-17-positive aggregates observed after A11-IP showed a spherical shape (arrowheads in J).
cases (Fig. 1H). LoMWA␤ and dimers were detected only after 3 hrs of chemiluminescence exposure but not in controls
A11-antibody and B10AP-antibody fragments precipitate oligomeric and protofibrillar/fibrillar proteins including A␤ oligomers, A␤ protofibrils and A␤ fibrils in AD cases
In controls, immunoelectron microscopy of A11-and B10AP-precipitated proteins revealed a high number of precipitated and aggregated proteins that did not contain A␤-positive material ( Fig. 2A-D) . There was no nonspecific labelling with anti-A␤1-17 in controls. B10AP-precipitated material exhibited a pattern that showed fibril-/ protofibril-like architectures ( Fig. 2A, B) whereas the proteins precipitated by A11 displayed a spherical pattern (Fig. 2C, D) .
In B10AP precipitates of the soluble fraction of AD brain homogenates, we observed protein aggregates with a fibril/protofibril-like pattern similar to that seen in controls. However, in AD brains a high number of A␤-positive protein aggregates were detected with anti-A␤1-17 ( Fig. 2E-G) . High-magnification analysis of anti-A␤1-17-labeled protein aggregates revealed a protofibril-like pattern (Fig. 2F, arrows) . However, a few amorphous protein aggregates (Fig. 2F, arrowheads) as well as fibrillar aggregates (Fig. 2G) (Fig. 2H-J) . Protofibril-like structures as seen in B10AP precipitates were not observed in A11 precipitates.
SDS treatment destroys native high-molecular weight A␤ 42 and A␤ 40 aggregates
Synthetic A␤42 and A␤40 formed oligomeric and protofibrillar aggregates as detectable by electron microscopy (Fig. 3A, B) . With 2-5 min. chemiluminescence exposure time, BN-PAGE blots revealed a monomer band and an additional prominent smear of A␤42-and A␤40 aggregates with a molecular weight Ͼ700 and 240 kD, respectively (Fig. 3C) . However, after longer exposure time of 2-3 hrs, we observed smeary bands at ~10 and ~50 kD in A␤42 preparations, whereas A␤40 preparations exhibited an additional dimer band that was not detectable in short chemiluminescence exposure blots ( Figs 1A, B, 3C) . In SDS-PAGE, we observed few high-molecular weight aggregates above 240 kD in A␤42 preparations but not in A␤40 preparations, whereas very prominent A␤ monomer, dimer and trimer bands were observed for both synthetic A␤42-and A␤40 preparations. In SDS-treated A␤40 preparations, tetramer and A␤*56 bands were present that were not seen in SDS-treated A␤42 preparations (Fig. 3D ). Figure 1A and [25, 26] .
Discussion
At first, the results reported here appear to contradict the findings of other authors, who argue that distinct loMWA␤ oligomers, such as dimers and A␤*56, are critical for the development of AD [3, 9, 27] . These authors provide evidence that loMWA␤ oligomer preparations received by size-exclusion chromatography are detectable in human as well as transgenic mouse brains, and are capable of inducing cognitive deficits in the rat [9] or altering longterm potentiation [3] . Given [28] . The relevance of soluble hiMWA␤ for the pathogenesis of AD may be further supported by the finding of neuritic degeneration near A␤ plaques, i.e. in areas with high levels of hiMWA␤ presumably dissolved from A␤ plaques, in the APP transgenic mouse brain [7, 8, 29] , in aged rhesus monkeys [30] and in the AD brain [31] , and also by the finding that dendritic degeneration in another APP-transgenic mouse model begins at the same time as the deposition of initial diffuse A␤-plaques, i.e. when hiMWA␤ aggregates begin to predominate in the cortex [32] .
Here, the stability of hiMWA␤42 aggregates was greater than that of A␤40 aggregates in in vitro experiments, thus confirming previous reports that soluble A␤42 aggregates are more stable than A␤40 aggregates [33, 34] . Taken together with our finding that hiMWA␤42 aggregates predominate in the native soluble fraction of the brain, it may be speculated that it is the stability of soluble A␤42 aggregates in the soluble compartment of the brain that accounts for its predominance in parenchymal A␤ plaque deposition [26] .
In 
